Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Double-dipping

How rumored Relypsa takeout could add to 5AM's returns

April 18, 2016 7:00 AM UTC

If takeout rumors about Relypsa Inc. (NASDAQ:RLYP) come true, 5AM Ventures is well positioned to improve upon the returns it has already achieved on the second of two lucrative sibling investments in chronic kidney disease (CKD).

On April 7, Relypsa gained $9.81 (68%) to $24.32 after media reports said the company is considering a sale. 5AM Ventures is already in the money following a series of open market sales of the stock after Relypsa's 2013 IPO. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article